ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: President Clinton Appoints Six New Members To The National Cancer Advisory Board

December 11, 1998

Arimidex Reduces Relapse Compared To Tamoxifen, Large Study Reports

December 28, 2001

In Brief: New DRCCA Recruits: Cullen Will Be Greenwalds’s Deputy, Frelick To Become CCOP Project Officer

April 2, 1982

Advocacy Group Tells Chicago Tribune That AIDS, Not Gallo, Is Issue

September 21, 1990

FDA Seeks Consumers For Advisory Committees.

November 23, 2001

Cooperative Group Chairmen Told They Must Do Their Own Planning, Will Get Funds Increase

September 26, 1975